Skip to main content

Posters

Showing 1 of 4

New

Real-World Outcomes After 2 Years of Dupilumab Therapy for Severe Asthma: The ProVENT Study

Confidential. For reactive use only by Sanofi Medical Affairs for scientific exchange purposes. Do not copy or distribute.